Literature DB >> 6373386

Studies on the effect of gonadotropin-releasing hormone and its agonist on human luteal steroidogenesis in vitro.

R F Casper, G F Erickson, S S Yen.   

Abstract

The possible direct effect of gonadotropin-releasing hormone (GnRH) and a potent GnRH agonist [( imBzl )-D- His6 -Pro9-NEt]-GnRH on basal and human chorionic gonadotropin (hCG)-stimulated progesterone, androstenedione, and estradiol production by cultured human luteal cells was examined. Luteal cells from the early or midluteal phase of the menstrual cycle responded to hCG stimulation with two to fivefold increases in steroid production in both short-term (4 hours) and long-term (up to 144 hours) culture in chemically defined medium without serum. After 48 hours in this system, levels of androstenedione and estradiol were very low, and progesterone was the predominant steroid produced. The addition of GnRH or a potent GnRH agonist to the medium had no effect on either basal or hCG-stimulated steroid secretion. When luteal cells were cultured longer (for up to 10 days) in the presence of serum, GnRH agonist caused no significant alteration of either basal or hCG-stimulated progesterone production. Collectively, these results support the conclusion that GnRH and its potent agonist do not act directly on human corpora luteal cells to modulate steroidogenesis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6373386     DOI: 10.1016/s0015-0282(16)47955-0

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  7 in total

1.  Improvement of IVF outcome in poor responders by discontinuation of GnRH analogue during the gonadotropin stimulation phase--a function of improved embryo quality.

Authors:  M Schachter; S Friedler; A Raziel; D Strassburger; O Bern; R Ron-el
Journal:  J Assist Reprod Genet       Date:  2001-04       Impact factor: 3.412

Review 2.  Histrelin. A review of its pharmacological properties and therapeutic role in central precocious puberty.

Authors:  L B Barradell; D McTavish
Journal:  Drugs       Date:  1993-04       Impact factor: 9.546

3.  The effect of leuprorelin on steroidogenesis of human preovulatory granulosa cells in vitro.

Authors:  R Fabbri; E Porcu; A Pession; E Sereni; T Marsella; R Seracchioli; C Flamigni
Journal:  J Assist Reprod Genet       Date:  1996-04       Impact factor: 3.412

4.  Gene expression of gonadotropin-releasing hormone in early pregnant rat and steroid hormone exposed mouse uteri.

Authors:  M Ikeda; M Taga; H Sakakibara; H Minaguchi; E Ginsburg; B K Vonderhaar
Journal:  J Endocrinol Invest       Date:  1996-12       Impact factor: 4.256

5.  Atypical response to luteinizing hormone-releasing hormone (LH-RH) agonist (suprefact nasal) in induction of ovulation in in vitro fertilization (IVF).

Authors:  J B Lessing; J R Cohen; I Yovel; A Amit; M P David; M R Peyser
Journal:  J In Vitro Fert Embryo Transf       Date:  1991-12

6.  Effect of in vivo GnRH agonist and GnRH antagonist on hCG and insulin-stimulated progesterone production by human granulosa-lutein cells in vitro.

Authors:  Mohamed F M Mitwally; Robert F Casper
Journal:  J Assist Reprod Genet       Date:  2002-08       Impact factor: 3.412

7.  Does gonadotropin-releasing hormone agonist cause luteolysis by inducing apoptosis of the human granulosa-luteal cells?

Authors:  Noa Gonen; Robert F Casper; Andrea Jurisicova; Yuval Yung; Moran Friedman-Gohas; Raoul Orvieto; Jigal Haas
Journal:  J Assist Reprod Genet       Date:  2021-05-24       Impact factor: 3.357

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.